Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis

Cellular Oncology

Volumn 30, Issue 1, 2008, Pages 77-87

  De Wilde, Jillian ^a   De Castro Arce, Johanna ^b   Snijders, Peter J F ^a   Meijer, Chris J L M ^a   Rösl, Frank ^b   Steenbergen, Renske D M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

AP 1; c Fos; CADM1; Cervical cancer; Fra 1; HPV; Net; Notch1

Indexed keywords

CELL ADHESION MOLECULE; CELL ADHESION MOLECULE 1; NOTCH1 RECEPTOR; PROTEIN C FOS; PROTEIN C JUN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FOSB; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CARCINOGENESIS; CARCINOGENICITY; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; UTERINE CERVIX CANCER; WART VIRUS;

CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; KERATINOCYTES; PAPILLOMAVIRUS INFECTIONS; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 38549170834     PISSN: 15705870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. A. Bachmann, B. Hanke, R. Zawatzky, U. Soto, J. van Riggelen, H. zur Hausen and F. Rosl, Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells, J. Virol. 76 (2002), 280-291.
2. C. Backsch, N. Wagenbach, M. Nonn, S. Leistritz, E. Stanbridge, A. Schneider and M. Durst, Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity, Gen. Chromosom. Cancer 31 (2001), 196-198.
3. A. Behren, C. Simon, R.M. Schwab, E. Loetzsch, S. Brodbeck, E. Huber, F. Stubenrauch, H.P. Zenner and T. Iftner, Papillomavirus E2 protein induces expression of the matrix metalloproteinase-9 via the extracellular signal-regulated kinase/ activator protein-1 signaling pathway, Cancer Res. 65 (2005), 11613-11621.
4. P.B. Bethwaite, J. Koreth, C.S. Herrington and J.O. McGee, Loss of heterozygosity occurs at the D11S29 locus on chromosome 11q23 in invasive cervical carcinoma, Br. J. Cancer 71 (1995), 814-818.
5. C.S. Brady, J.S. Bartholomew, D.J. Burt, M.F. Duggan-Keen, S. Glenville, N. Telford, A.M. Little, J.A. Davidson, P. Jimenez, F. Ruiz-Cabello, F. Garrido and P.L. Stern, Multiple mechanisms underlie HLA dysregulation in cervical cancer, Tissue Antigens 55 (2000), 401-411.
6. G. Buchwalter, C. Gross and B. Wasylyk, Ets ternary complex transcription factors, Gene 324 (2004), 1-14.
7. K. Butz and F. Hoppe-Seyler, Transcriptional control of human papillomavirus (HPV) oncogene expression: composition of the HPV type 18 upstream regulatory region, J. Virol. 67 (1993), 6476-6486.
8. T.M. Chen, G. Pecoraro and V. Defendi, Genetic analysis of in vitro progression of human papillomavirus-transfected human cervical cells, Cancer Res. 53 (1993), 1167-1171.
9. J. De-Castro Arce, U. Soto, J. van Riggelen, E. Schwarz, H. zur Hausen and F. Rosl, Ectopic expression of nonliganded retinoic acid receptor beta abrogates AP-1 activity by selective degradation of c-Jun in cervical carcinoma cells, J. Biol. Chem. 279 (2004), 45408-45416.
10. R. Eferl and E.F. Wagner, AP-1: a double-edged sword in tumorigenesis, Nat. Rev. Cancer 3 (2003), 859-868.
11. M. el Bahassi, S. Karyala, C.R. Tomlinson, M.A. Sartor, M. Medvedovic and R.F. Hennigan, Critical regulation of genes for tumor cell migration by AP-1, Clin. Exp. Metastasis 21 (2004), 293-304.
12. A. Giovane, P. Sobieszczuk, A. Ayadi, S.M. Maira and B. Wasylyk, Net-b, a Ras-insensitive factor that forms ternary complexes with serum response factor on the serum response element of the fos promoter, Mol. Cell. Biol. 17 (1997), 5667-5678.
13. G.M. Hampton, L.A. Penny, R.N. Baergen, A. Larson, C. Brewer, S. Liao, R.M. Busby-Earle, A.W. Williams, C.M. Steel and C.C. Bird, Loss of heterozygosity in cervical carcinoma: subchromosomal localization of a putative tumor-suppressor gene to chromosome 11q22-q24, Proc. Natl. Acad. Sci. USA 91 (1994), 6953-6957.
14. R.A. Jesudasan, R.A. Rahman, S. Chandrashekharappa, G.A. Evans and E.S. Srivatsan, Deletion and translocation of chromosome 11q13 sequences in cervical carcinoma cell lines, Am. J. Hum. Genet. 56 (1995), 705-715.
15. M. Koi, H. Morita, H. Yamada, H. Satoh, J.C. Barrett and M. Oshimura, Normal human chromosome 11 suppresses tumorigenicity of human cervical tumor cell line SiHa, Mol. Carcinog. 2 (1989), 12-21.
16. S. Kyo, D.J. Klumpp, M. Inoue, T. Kanaya and L.A. Laimins, Expression of AP1 during cellular differentiation determines human papillomavirus E6/E7 expression in stratified epithelial cells, J. Gen. Virol. 78 (1997), 401-411.
17. S. Kyo, A. Tam and L.A. Laimins, Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors, Virology 211 (1995), 184-197.
18. S. Lathion, J. Schaper, P. Beard and K. Raj, Notch1 can contribute to viral-induced transformation of primary human keratinocytes, Cancer Res. 63 (2003), 8687-8694.
19. W. Lee, P. Mitchell and R. Tjian, Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements, Cell 49 (1987), 741-752.
20. C. Mugica-Van Herckenrode, J.A. Rodriguez, V. Iriarte-Campo, A. Carracedo and F. Barros, Definition of a region of loss of heterozygosity at chromosome 11q in cervical carcinoma, Diagn. Mol. Pathol. 8 (1999), 92-96.
21. N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders and C.J. Meijer, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N. Engl. J. Med. 348 (2003), 518-527.
22. M. Nees, J.M. Geoghegan, T. Hyman, S. Frank, L. Miller and C.D. Woodworth, Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes, J. Virol. 75 (2001), 4283-4296.
23. M.J. O'sullivan, J.S. Rader, D.S. Gerhard, Y. Li, K.M. Trinkaus, D.J. Gersell and P.C. Huettner, Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix, Hum. Pathol. 32 (2001), 475-478.
24. M. Poignee, C. Backsch, K. Beer, L. Jansen, N. Wagenbach, E.J. Stanbridge, R. Kirchmayr, A. Schneider and M. Durst, Evidence for a putative senescence gene locus within the chromosomal region 10p14-p15, Cancer Res. 61 (2001), 7118-7121.
25. B.K. Prusty and B.C. Das, Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin, Int. J. Cancer 113 (2005), 951-960.
26. F. Rosl, B.C. Das, M. Lengert, K. Geletneky and H. zur Hausen, Antioxidant-induced changes of the AP-1 transcription complex are paralleled by a selective suppression of human papillomavirus transcription, J. Virol. 71 (1997), 362-370.
27. P.J. Saxon, E.S. Srivatsan and E.J. Stanbridge, Introduction of human chromosome 11 via microcell transfer controls tumorigenic expression of HeLa cells, EMBO J. 5 (1986), 3461-3466.
28. U. Soto, B.C. Das, M. Lengert, P. Finzer, H. zur Hausen and F. Rosl, Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex, Oncogene 18 (1999), 3187-3198.
29. U. Soto, C. Denk, P. Finzer, K.J. Hutter, H. zur Hausen and F. Rosl, Genetic complementation to non-tumorigenicity in cervical-carcinoma cells correlates with alterations in AP-1 composition, Int. J. Cancer 86 (2000), 811-817.
30. E.S. Srivatsan, B.C. Misra, M. Venugopalan and S.P. Wilczynski, Loss of heterozygosity for alleles on chromosome 11 in cervical carcinoma, Am. J. Hum. Genet. 49 (1991), 868-877.
31. E.J. Stanbridge, Genetic analysis of tumorigenicity in human cell hybrids, Cancer Surv. 3 (1984), 335-350.
32. E.J. Stanbridge, R.R. Flandermeyer, D.W. Daniels and W.A. Nelson-Rees, Specific chromosome loss associated with the expression of tumorigenicity in human cell hybrids, Somat. Cell Genet. 7 (1981), 699-712.
33. R.D. Steenbergen, J. de Wilde, S.M. Wilting, A.A. Brink, P.J. Snijders and C.J. Meijer, HPV-mediated transformation of the anogenital tract, J. Clin. Virol. 32(Suppl. 1) (2005), S25-S33.
34. R.D. Steenbergen, M.A. Hermsen, J.M. Walboomers, G.A. Meijer, J.P. Baak, C.J. Meijer and P.J. Snijders, Non-random allelic losses at 3p, 11p and 13q during HPV-mediated immortalization and concomitant loss of terminal differentiation of human keratinocytes, Int. J. Cancer 76 (1998), 412-417.
35. R.D. Steenbergen, D. Kramer, B.J. Braakhuis, P.L. Stern, R.H. Verheijen, C.J. Meijer and P.J. Snijders, TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia, J. Natl. Cancer Inst. 96 (2004), 294-305.
36. R.D. Steenbergen, D. Kramer, C.J. Meijer, J.M. Walboomers, D.A. Trott, A.P. Cuthbert, R.F. Newbold, W.J. Overkamp, M.Z. Zdzienicka and P.J. Snijders, Telomerase suppression by chromosome 6 in a human papillomavirus type 16-immortalized keratinocyte cell line and in a cervical cancer cell line, J. Natl. Cancer Inst. 93 (2001), 865-872.
37. R.D. Steenbergen, J.N. Parker, S. Isern, P.J. Snijders, J.M. Walboomers, C.J. Meijer, T.R. Broker and L.T. Chow, Viral E6-E7 transcription in the basal layer of organotypic cultures without apparent p21cip1 protein precedes immortalization of human papillomavirus type 16- and 18-transfected human keratinocytes, J. Virol. 72 (1998), 749-757.
38. R.D. Steenbergen, J.M. Walboomers, C.J. Meijer, E.M. van der Raaij-Helmer, J.N. Parker, L.T. Chow, T.R. Broker and P.J. Snijders, Transition of human papillomavirus type 16 and 18 transfected human foreskin keratinocytes towards immortality: activation of telomerase and allele losses at 3p, 10p, 11q and/or 18q, Oncogene 13 (1996), 1249-1257.
39. C. Talora, S. Cialfi, O. Segatto, S. Morrone, C.J. Kim, L. Frati, D.G. Paolo, A. Gulino and I. Screpanti, Constitutively active Notch1 induces growth arrest of HPV-positive cervical cancer cells via separate signaling pathways, Exp. Cell Res. 305 (2005), 343-354.
40. C. Talora, D.C. Sgroi, C.P. Crum and G.P. Dotto, Specific down-modulation of Notch1 signaling in cervical cancer cells is required for sustained HPV-E6/E7 expression and late steps of malignant transformation, Genes Dev. 16 (2002), 2252-2263.
41. J. van Riggelen, G. Buchwalter, U. Soto, J. De-Castro Arce, H. zur Hausen, B. Wasylyk and F. Rosl, Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells, J. Biol. Chem. 280 (2005), 3286-3294.
42. J.M. Walboomers, M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer, K.V. Shah, P.J. Snijders, J. Peto, C.J. Meijer and N. Munoz, Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J. Pathol. 189 (1999), 12-19.
43. S. Weijzen, A. Zlobin, M. Braid, L. Miele and W.M. Kast, HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation, J. Cell. Physiol. 194 (2003), 356-362.
44. B.A. Westerman, S. Neijenhuis, A. Poutsma, R.D. Steenbergen, R.H. Breuer, M. Egging, I.J. van Wijk and C.B. Oudejans, Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features, Clin. Cancer Res. 8 (2002), 1082-1086.
45. S.M. Wilting, P.J. Snijders, G.A. Meijer, B. Ylstra, P.R. van den Ijssel, A. Snijders, D. Albertson, J. Coffa, J. Schouten, M.A. van de Wiel, C.J. Meijer and R.D. Steenbergen, Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix, J. Pathol. 209(2) (2006), 220-230.